Skip to content

Components at other companies

Coastal Financial logo
Coastal FinancialCCB
9+12.5%
Azenta logo
AzentaAZTA
$37.41M
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
22+57.1%
ASI
Ategrity Specialty Insurance Company HoldingsASIC
39
Trupanion logo
TrupanionTRUP
70
Horizon Bancorp logo
Horizon BancorpHBNC
843-100.0%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's components.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's components?
Integra LifeSciences (IART) reported components of $132.21M in Q1 2026.
How has Integra LifeSciences's components changed year-over-year?
Integra LifeSciences's components increased by 3.8% year-over-year, from $127.42M to $132.21M.
What is the long-term trend for Integra LifeSciences's components?
Over 5 years (2020 to 2025), Integra LifeSciences's components has grown at a 11.3% compound annual growth rate (CAGR), from $76.48M to $130.77M.
What does components mean?
This represents a granular breakdown or specific sub-category of a larger financial statement line item. It is used to provide transparency into the composition of complex balance sheet or income statement accounts. Investors analyze these components to understand the underlying drivers of specific financial performance metrics.